Matthew W. Cravets

机构：Western University, University of California San Diego, Robarts Clinical Trials, Inceptus (United States)

发表论文 9 篇 · 总被引 2547 次 · h-index 5

代表论文

• Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks (2006 · Arthritis & Rheumatism · 被引 1650)
• Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis (2016 · New England Journal of Medicine · 被引 453)
• Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open‐label extension analysis (2007 · Arthritis & Rheumatism · 被引 337)
• Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol (2016 · Annals of the Rheumatic Diseases · 被引 101)
• Efficacy Results of the Phase 2 Portion of the RADIANCE Trial: A Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 in Adults with Relapsing Multiple Sclerosis (P7.198) (2015 · Neurology · 被引 5)
• Safety and Tolerability Results of the Phase 2 Portion of the RADIANCE Trial: A Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 in Relapsing Multiple Sclerosis (P7.199) (2015 · Neurology · 被引 1)